Polyflex Epicardial 439-04 Implant Pacing Lead
510(k) K874531
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK874531 | Date7 Jan 1988 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Polyflex(R) Epicardial 439-04 Implant Pacing Lead
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Polyflex Epicardial 439-04 Implant Pacing Lead is a permanent pacemaker electrode designed for epicardial placement. It delivers electrical stimulation to regulate heart rhythm in patients requiring cardiac pacing, typically those with bradycardia or conduction system disorders.
This lead is intended for surgical implantation during open-chest procedures, where it is positioned on the epicardial surface of the heart. Supplied sterile and intended for single-use, it is classified as a Class III medical device under FDA regulations. The device is authorized through an FDA 510(k) clearance (K874531) and adheres to the regulatory requirements outlined in 21 CFR 870.3680.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What types of patients is this epicardial pacing lead designed for, and how is it implanted?
This lead is designed for patients requiring cardiac pacing due to bradycardia or conduction system disorders. It is intended for surgical implantation during open-chest procedures, where it is positioned on the epicardial surface of the heart to deliver electrical stimulation and regulate heart rhythm.
Is the Polyflex Epicardial 439-04 Implant Pacing Lead reusable or single-use, and how is it supplied?
The lead is supplied sterile and intended for single-use only. It comes pre-packaged for immediate surgical use, ensuring sterility and minimizing risk of contamination.
What regulatory pathway was followed for FDA clearance of this device, and what class does it fall under?
The Polyflex Epicardial 439-04 Implant Pacing Lead received FDA 510(k) clearance (K874531) under the traditional review pathway, with a decision of *Substantially Equivalent* (SESE). It is classified as a Class III medical device under FDA regulations, reflecting its role in life-sustaining or life-supporting functions.
How is this lead differentiated from other permanent pacemaker electrodes, and what surgical context is it intended for?
This lead is specifically designed for epicardial placement, meaning it is surgically positioned on the outer surface of the heart during open-chest procedures. Unlike transvenous leads, it requires direct access to the heart tissue, making it suitable for cases where epicardial pacing is clinically indicated, such as in congenital heart disease or certain arrhythmias.